CLINICAL_TRIALS
research
· 2025-12-31
Clinical Trial Update: Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis [Phase 1]
Summary
A Phase 1 study evaluating circadian-focused light therapy for progressive multiple sclerosis is currently enrolling by invitation, sponsored by the University …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Progressive Multiple Sclerosis | Phase 1 | Status: ENROLLING_BY_INVITATION